Systematic approach to selecting licensed drugs for repurposing in the treatment of progressive multiple sclerosis | Journal of Neurology, Neurosurgery & Psychiatry

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

JNNP 100

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Multiple sclerosis

Original research

Systematic approach to selecting licensed drugs for repurposing in the treatment of progressive multiple sclerosis

Free

Online download statistics by month:

Online download statistics by month: November 2020 to November 2022

	Abstract	Full	Pdf
Nov 2020	2580	114	69
Dec 2020	1049	30	15
Jan 2021	469	30	11
Feb 2021	589	432	96
Mar 2021	525	511	188
Apr 2021	240	227	125
May 2021	211	184	100
Jun 2021	180	176	78
Jul 2021	142	135	75
Aug 2021	167	164	70
Sep 2021	193	184	150
Oct 2021	208	193	119
Nov 2021	190	182	81
Dec 2021	138	137	66
Jan 2022	170	170	83
Feb 2022	161	161	72
Mar 2022	177	174	53
Apr 2022	158	153	56
May 2022	179	160	78
Jun 2022	146	132	40
Jul 2022	174	166	49
Aug 2022	133	119	49
Sep 2022	109	106	42
Oct 2022	155	141	58
Nov 2022	240	227	61
Total	8683	4408	1884